Preoperative BRAF Mutation is Predictive of Occult Contralateral Carcinoma in Patients with Unilateral Papillary Thyroid Microcarcinoma |
Zhou, Yi-Li
(Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College)
Zhang, Wei (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) Gao, Er-Li (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) Dai, Xuan-Xuan (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) Yang, Han (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) Zhang, Xiao-Hua (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) Wang, Ou-Chen (Department of Oncology, The First Affiliated Hospital of Wenzhou Medical College) |
1 | Baudin E, Travagli JP, Ropers J, et al (1998). Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer, 83, 553-9. DOI ScienceOn |
2 | Chow SM, Law SC, Chan JK, et al (2003). Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer, 98, 31-40. DOI ScienceOn |
3 | Connor MP, Wells D, Schmalbach CE (2011). Variables predictive of bilateral occult papillary microcarcinoma following total thyroidectomy. Otolaryngol Head Neck Surg, 144, 210-5. DOI |
4 | Cooper DS, Doherty GM, Haugen BR, et al (2006). Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 16, 109-42. DOI ScienceOn |
5 | Cooper DS, Doherty GM, Haugen BR, et al (2009). Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-214. DOI ScienceOn |
6 | Davies L, Welch HG (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295, 2164-7. DOI ScienceOn |
7 | Elisei R, Ugolini C, Viola D, et al (2008). BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab, 93, 3943-9. DOI |
8 | Grant CS, Hay ID, Gough IR, et al (1988). Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery, 104, 954-62. |
9 | Gu LQ, Li FY, Zhao L, et al (2009). BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma. Thyroid, 19, 347-54. DOI |
10 | Hay ID, Grant CS, Taylor WF, et al (1987). Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery, 102, 1088-95. |
11 | Hay ID, Hutchinson ME, Gonzalez-Losada, et al (2008). Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery, 144, 980-7; discussion 987-8. DOI |
12 | Hwang E, Pakdaman MN, Black MJ, et al (2008). Tumour Size and Bilateral Thyroid Cancer after Thyroidectomy. J Otolaryngol Head Neck Surg, 139, 47. DOI |
13 | Hwang E, Pakdaman MN, Tamilia M, et al (2010). Bilateral papillary thyroid cancer and associated histopathologic findings. J Otolaryngol Head Neck Surg, 39, 284-7. |
14 | Ito Y, Uruno T, Nakano K, et al (2003). An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid, 13, 381-7. DOI ScienceOn |
15 | Jacquot-Laperriere S, Timoshenko AP, Dumollard JM, et al (2007). Papillary thyroid microcarcinoma: incidence and prognostic factors. Eur Arch Otorhinolaryngol, 264, 935-9. DOI ScienceOn |
16 | Lin KL, Wang OC, Zhang XH, et al (2010). The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann Surg Oncol, 17, 3294-300. DOI |
17 | Kim ES, Kim TY, Koh JM, et al (2004). Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation. Clin Endocrinol (Oxf), 61, 145-8. DOI ScienceOn |
18 | Kimura ET, Nikiforova MN, Zhu Z, et al (2003). High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res, 63, 1454-7. |
19 | Koo BS, Lim HS, Lim YC, et al (2010). Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma. Ann Surg Oncol, 17, 1101-5. DOI |
20 | Mercante G, Frasoldati A, Pedroni C, et al (2009). Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid, 19, 707-16. DOI |
21 | Pacini F, Elisei R, Capezzone M, et al (2001). Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid, 11, 877-81. DOI |
22 | Nikiforova MN, Kimura ET, Gandhi M, et al (2003). BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab, 88, 5399-404. DOI ScienceOn |
23 | Noguchi S, Yamashita H, Murakami N, et al (1996). Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg, 131, 187-91. DOI |
24 | Oler G, Cerutti JM (2009). High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer, 115, 972-80. DOI |
25 | Pasieka JL, Thompson NW, McLeod MK, et al (1992). The incidence of bilateral well-differentiated thyroid cancer found at completion thyroidectomy. World J Surg, 16, 711- 6; discussion 716-7. DOI |
26 | Pelizzo MR, Boschin IM, Toniato A, et al (2006). Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 32, 1144-8. DOI ScienceOn |
27 | Shindo M, Wu JC, Park EE, et al (2006). The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg, 132, 650-4. DOI ScienceOn |
28 | Pitt SC, Sippel RS, and Chen H (2009). Contralateral papillary thyroid cancer: does size matter? Am J Surg, 197, 342-7. DOI |
29 |
Schonberger J, Marienhagen J, Agha A, et al (2007). Papillary microcarcinoma and papillary cancer of the thyroid |
30 | Sherman SI (2003). Thyroid carcinoma. Lancet, 361, 501-11. DOI |
31 | Wang W, Wang H, Teng X, et al (2010). Clonal analysis of bilateral, recurrent, and metastatic papillary thyroid carcinomas. Hum Pathol, 41, 1299-309. DOI |
32 | Zheng W, Zhang Z (2007). An analysis of cancer incidence in 2005 in Lucheng District, Wenzhou City, Zhejiang Province. Bulletin of Chinese Cancer, 16, 306-8. |
33 | Wang W, Zhao W, Wang H, et al (2012). Poorer prognosis and higher prevalence of BRAF (V600E) mutation in synchronous bilateral papillary thyroid carcinoma. Ann Surg Oncol, 19, 31-6. DOI |
34 | Xing M (2007). BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev, 28, 742-62. DOI ScienceOn |
![]() |